← Issue №20/ week of Nov 15, 2026/IBD

Interpretable machine learning applied to high-dimensional salivary proteomics in pediatric inflammatory bowel diseases.

From GI Signals issue №20: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

IBD prospective cohort · Nov 9, 2026 · Inflamm Bowel Dis · IF 4.5

Interpretable machine learning applied to high-dimensional salivary proteomics in pediatric inflammatory bowel diseases.

Basic sciencepediatricartificial intelligencebiomarkertranslational
Clinical takeawayNo clinical action yet: a proof-of-concept study demonstrating potential for noninvasive IBD classification in pediatric patients.
What it foundA 14-protein salivary signature achieved 97.5% balanced accuracy in classifying pediatric IBD at first visit and 80.2% in follow-up samples.
ContextChallenges current invasive and delayed diagnostic methods, offering a potential noninvasive alternative for pediatric IBD classification.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Rupp BT … Byrd KM · Inflammatory Bowel Diseases · IF 4.5 · PubMed ↗Permalink
← Read the whole of issue №20 Every paper GI Signals surfaces gets a page like this one. All issues